Clear All
12159 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
71332-0006-60 71332-0006 Pralsetinib Gavreto 100.0 mg/1 Chemotherapy Enzyme Inhibitor RET, DDR1, TRKC, FLT3, JAK1/2, TRKA, VEGFR2, PDGFRB, FGFR1 Oral Jun 24, 2024 In Use
69171-0398-01 69171-0398 Irinotecan Hydrochloride Onivyde 4.3 mg/mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Oct 22, 2015 Sep 30, 2019 No Longer Used
63323-0117-61 63323-0117 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jul 12, 2000 In Use
55150-0511-10 55150-0511 METHOTREXATE METHOTREXATE 100.0 mg/4mL Chemotherapy Antimetabolite Folic Acid Analog Intramuscular, Intrathecal, Intravenous, Subcutaneous Sep 11, 2024 In Use
68001-0573-41 68001-0573 Decitabine DECITABINE 50.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Intravenous May 23, 2023 In Use
54868-5980-00 54868-5980 Temozolomide Temodar 180.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Jan 26, 2009 In Use
68001-0265-22 68001-0265 Etoposide Etoposide 20.0 mg/mL Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Nov 14, 2013 In Use
39822-2180-01 39822-2180 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Apr 17, 2017 Jul 31, 2020 In Use
16714-0930-01 16714-0930 GEMCITABINE HYDROCHLORIDE GEMCITABINE 1.0 g/1 Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Nov 1, 2018 In Use
61703-0339-50 61703-0339 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Oct 14, 2004 In Use
63739-0932-11 63739-0932 Docetaxel Docetaxel 20.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Jan 1, 2015 Mar 31, 2017 In Use
63850-0059-04 63850-0059 Everolimus Everolimus 5.0 mg/1 Chemotherapy Enzyme Inhibitor mTOR Oral May 26, 2023 In Use
75007-0501-31 75007-0501 Bortezomib Bortezomib 3.5 mg/1 Chemotherapy Proteasome Inhibitor 26S Intravenous, Subcutaneous Dec 17, 2025 In Use
51862-0088-51 51862-0088 Temozolomide Temozolomide 250.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral Oct 10, 2016 Sep 30, 2019 No Longer Used
55390-0084-01 55390-0084 Mitoxantrone Mitoxantrone Chemotherapy Antitumor Antibiotic Anthracenedione Intravenous Apr 11, 2006 May 31, 2010 No Longer Used
63629-9530-01 63629-9530 Doxorubicin hydrochloride Doxorubicin hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Dec 12, 2022 Apr 30, 2024 No Longer Used
00069-0076-01 00069-0076 Paclitaxel Paclitaxel 100.0 mg/16.7mL Chemotherapy Antimitotic Agent Taxane Intravenous Sep 30, 2011 Dec 31, 2016 No Longer Used
71258-0015-02 71258-0015 iobenguane I-131 Azedra 15.0 mCi/mL Chemotherapy Radiopharmaceutical I 131 Intravenous Jul 30, 2018 In Use
69097-0031-91 69097-0031 Nilotinib Nilotinib 150.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Jun 18, 2025 In Use
00703-4100-68 00703-4100 Ifosfamide and Mesna Ifosfamide and Mesna Chemotherapy Alkylating Agent Nitrogen Mustard Intravenous Feb 26, 2002 Feb 25, 2010 No Longer Used
44567-0509-01 44567-0509 Cisplatin Cisplatin 1.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Jan 13, 2012 In Use
42291-0939-12 42291-0939 Pazopanib Pazopanib 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, PDGFR, FGFR, Kit, Itk, Lck, c-Fms Oral Apr 23, 2024 In Use
54868-5474-00 54868-5474 Erlotinib Hydrochloride Tarceva 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral Nov 21, 2005 In Use
00019-9452-09 00019-9452 Sodium Iodide I-131 Sodium Iodide I-131 1.0 mCi/mL Chemotherapy Radiopharmaceutical Iodine 131 Oral Jan 25, 2012 Jul 1, 2017 No Longer Used
59651-0542-60 59651-0542 DASATINIB DASATINIB 20.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Apr 22, 2025 In Use

Found 12159 results — Export these results